Knower KC[Author] - Search Results

Year	Number of Results
2003	1
2007	1
2008	1
2010	3
2011	1
2012	4
2013	6
2014	5
2015	1
2018	2
2024	0

1

Endocrine disruption of the epigenome: a breast cancer link.

Knower KC, To SQ, Leung YK, Ho SM, Clyne CD. Knower KC, et al. Endocr Relat Cancer. 2014 Mar 12;21(2):T33-55. doi: 10.1530/ERC-13-0513. Print 2014 Apr. Endocr Relat Cancer. 2014. PMID: 24532474 Free PMC article. Review.

2

Transcriptional control of local estrogen formation by aromatase in the breast.

To SQ, Knower KC, Cheung V, Simpson ER, Clyne CD. To SQ, et al. Among authors: knower kc. J Steroid Biochem Mol Biol. 2015 Jan;145:179-86. doi: 10.1016/j.jsbmb.2014.05.004. Epub 2014 May 17. J Steroid Biochem Mol Biol. 2015. PMID: 24846828 Review.

3

Intracrine oestrogen production and action in breast cancer: an epigenetic focus.

Knower KC, To SQ, Clyne CD. Knower KC, et al. J Steroid Biochem Mol Biol. 2013 Sep;137:157-64. doi: 10.1016/j.jsbmb.2013.01.009. Epub 2013 Jan 20. J Steroid Biochem Mol Biol. 2013. PMID: 23339934 Review.

4

Origins and actions of tumor necrosis factor α in postmenopausal breast cancer.

To SQ, Knower KC, Clyne CD. To SQ, et al. Among authors: knower kc. J Interferon Cytokine Res. 2013 Jul;33(7):335-45. doi: 10.1089/jir.2012.0155. Epub 2013 Mar 8. J Interferon Cytokine Res. 2013. PMID: 23472660 Review.

5

Turning on the male--SRY, SOX9 and sex determination in mammals.

Knower KC, Kelly S, Harley VR. Knower KC, et al. Cytogenet Genome Res. 2003;101(3-4):185-98. doi: 10.1159/000074336. Cytogenet Genome Res. 2003. PMID: 14684982 Review.

6

Timeless Is a Novel Estrogen Receptor Co-activator Involved in Multiple Signaling Pathways in MCF-7 Cells.

Magne Nde CB, Casas Gimeno G, Docanto M, Knower KC, Young MJ, Buehn J, Sayed E, Clyne CD. Magne Nde CB, et al. Among authors: knower kc. J Mol Biol. 2018 May 11;430(10):1531-1543. doi: 10.1016/j.jmb.2018.03.008. Epub 2018 Mar 16. J Mol Biol. 2018. PMID: 29555554

7

Estrogen receptor status of breast stromal cells.

Knower KC, Chand AL, Clyne CD. Knower KC, et al. Breast Cancer Res Treat. 2014 Feb;143(3):609-10. doi: 10.1007/s10549-014-2837-6. Breast Cancer Res Treat. 2014. PMID: 24464576 No abstract available.

8

Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.

Sreenivasan R, Ludbrook L, Fisher B, Declosmenil F, Knower KC, Croft B, Bird AD, Ryan J, Bashamboo A, Sinclair AH, Koopman P, McElreavey K, Poulat F, Harley VR. Sreenivasan R, et al. Among authors: knower kc. Hum Mutat. 2018 Dec;39(12):1861-1874. doi: 10.1002/humu.23603. Epub 2018 Aug 22. Hum Mutat. 2018. PMID: 30067310

9

Distinct nuclear receptor expression in stroma adjacent to breast tumors.

Knower KC, Chand AL, Eriksson N, Takagi K, Miki Y, Sasano H, Visvader JE, Lindeman GJ, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Graham J, Muscat GE, Clarke CL, Clyne CD. Knower KC, et al. Breast Cancer Res Treat. 2013 Nov;142(1):211-23. doi: 10.1007/s10549-013-2716-6. Breast Cancer Res Treat. 2013. PMID: 24122391

10

Mutations of the SRY-responsive enhancer of SOX9 are uncommon in XY gonadal dysgenesis.

Georg I, Bagheri-Fam S, Knower KC, Wieacker P, Scherer G, Harley VR. Georg I, et al. Among authors: knower kc. Sex Dev. 2010;4(6):321-5. doi: 10.1159/000320142. Epub 2010 Sep 14. Sex Dev. 2010. PMID: 20838034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year